Tissue Kallikreins (Tissue Kallikrein)

Subscribe to Selected New Research on Tissue Kallikreins

597 relevant articles (19 outcomes, 66 trials/studies) found for this Bio-Agent

Description: A family of trypsin-like SERINE ENDOPEPTIDASES that are expressed in a variety of cell types including human prostate epithelial cells. They are formed from tissue prokallikrein by action with TRYPSIN. They are highly similar to PROSTATE-SPECIFIC ANTIGEN. EC 3.4.21.35.

Also Known As:

Tissue Kallikrein; Kallikrein, Prostate Specific; Glandular Kallikrein; Glandular Kallikrein-1; Kallikrein 1; Kallikrein 2; Prostate Specific Kallikrein; 1, Kallikrein; 2, Kallikrein; Glandular Kallikrein 1; Glandular Kallikreins, Human; Kallikrein, Glandular; Kallikrein, Pancreatic; Kallikrein, Tissue; Kallikrein, Urinary; Kallikrein, hK1; Kallikrein, hK2; Kallikrein-1, Glandular; Kallikreins, Human Glandular; Kallikreins, Tissue; Specific Kallikrein, Prostate; Human Glandular Kallikrein 1; Human Glandular Kallikrein 2; Human Glandular Kallikreins; Pancreatic Kallikrein; Urinary Kallikrein; hK1 Kallikrein; hK2 Kallikrein

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Diamandis, Eleftherios P: 19 articles (09/2008 - 05/2002)
2.	Chao, Julie: 12 articles (06/2008 - 03/2002)
3.	Chao, Lee: 12 articles (06/2008 - 03/2002)
4.	Lilja, Hans: 8 articles (02/2007 - 08/2002)
5.	Diamandis, E P: 6 articles (07/2008 - 02/2000)
6.	Lilja, H: 6 articles (10/2001 - 01/2000)
7.	Yin, Hang: 5 articles (01/2008 - 06/2006)
8.	Madeddu, Paolo: 5 articles (04/2007 - 01/2003)
9.	Pettersson, Kim: 5 articles (02/2007 - 08/2002)
10.	Chao, L: 5 articles (09/2005 - 08/2000)

Related Diseases

1.	Hypertension (High Blood Pressure) 07/01/2008 - "CONCLUSION: Our study indicates that rAAV-mediated human tissue kallikrein gene delivery is a potentially safe method for the long-term treatment of hypertension" 09/01/2007 - "OBJECTIVE: The aim of this study was to investigate the association between common variants in the human tissue kallikrein 1 (KLK1) gene and susceptibility to essential hypertension in Chinese Han" 09/01/2007 - "A coding polymorphism of the kallikrein 1 gene is associated with essential hypertension: a tagging SNP-based association study in a Chinese Han population." 09/01/2005 - "This present study aimed to study the polymorphisms of the regulatory region of human tissue kallikrein gene of the Chinese and investigate the relationship of the polymorphisms with essential hypertension" 06/01/1997 - "The high variability and the proximity to the tissue kallikrein gene render it suitable for application as a new tool in genetic studies for evaluation of the tissue kallikrein gene in the pathogenesis of human essential hypertension." Order ALL the reference details at left...
2.	Prostatic Neoplasms (Prostate Cancer) 09/01/2003 - "measurement of human glandular kallikrein 2 (hK2) serves as a complementary marker to PSA for early detection of prostate cancer and constitutes a considerable improvement over PSA as a staging marker for clinically localized prostate cancer" 04/01/2003 - "BACKGROUND: Measurement of human kallikrein 2 (hK2) has improved early detection and staging of prostate cancer" 09/01/2005 - "In this study, we now show that the comparative expression of hK4 protein in prostate cancer tissues, compared with benign glands, is greater than that of PSA and kallikrein 2 (KLK2/hK2), suggesting that hK4 may play an important functional role in prostate cancer progression in addition to its biomarker potential" 02/15/2003 - "BACKGROUND: In recent studies serum levels of human glandular kallikrein 2 (hK2) demonstrated significant differences in pathologically organ-confined versus non-organ-confined prostate cancer (PCa)" 02/01/2003 - "RESULTS: We analyzed and systematized data from studies regarding the effectiveness of PSA and human glandular kallikrein 2 and their derivatives in the detection of prostate cancer" Order ALL the reference details at left...
3.	Ischemia 04/01/2004 - "Prophylactic gene therapy with human tissue kallikrein ameliorates limb ischemia recovery in type 1 diabetic mice." 03/04/2005 - "Our previous study has shown that human tissue kallikrein protected against ischemia/reperfusion-induced myocardial injury" 04/01/2004 - "The present study investigated whether prophylactic gene therapy with human tissue kallikrein (hTK) may protect diabetic limbs from the consequences of supervening ischemia" 06/01/2008 - "Tissue kallikrein and kinin infusion promotes neovascularization in limb ischemia." 10/15/2006 - "Rats were infused with tissue kallikrein protein 5 days before (pretreated group) or after (treated group) ischemia" Order ALL the reference details at left...
4.	Myocardial Infarction 10/01/2008 - "One day after myocardial infarction, tissue kallikrein treatment significantly improved cardiac contractility and reduced myocardial infarct size and left ventricle end diastolic pressure in Brown Norway Katholiek rats" 04/01/2008 - "Tissue kallikrein deficiency aggravates cardiac remodelling and decreases survival after myocardial infarction in mice." 02/01/2008 - "New perspective on the tissue kallikrein-kinin system in myocardial infarction: role of angiogenesis and cardiac regeneration." 09/01/2007 - "Tissue kallikrein and kinin infusion rescues failing myocardium after myocardial infarction." 04/05/2007 - "We investigated the effect of tissue kallikrein infusion on cardiac protection at acute and sub-acute phases after myocardial infarction (MI)" Order ALL the reference details at left...
5.	Inflammation 08/01/1994 - "Inhibitors of tissue kallikrein may prove effective in the treatment of allergic inflammation in man." 04/01/2005 - "The further observation of an increased tissue kallikrein activity at the systemic and saliva levels may be interpreted as a systemic reflex of skin inflammation" 07/01/2000 - "The pharmacological activity of phenylacetyl-Phe-Ser-Arg-N-(2, 4-dinitrophenyl)-ethylenediamine (TKI), a tissue kallikrein specific inhibitor, was assessed using models of nociception and inflammation in mice" 08/01/1994 - "Synthetic inhibitors of tissue kallikrein: effects in vivo in a model of allergic inflammation." 01/01/1989 - "Specimens of the gastric mucosa were obtained by biopsy to measure tissue kallikrein as a marker of inflammation" Order ALL the reference details at left...

Related Drugs and Biologics

1.	Kallikreins (Kallikrein)
2.	Renin
3.	Prostate-Specific Antigen (Semenogelase)
4.	Sodium
5.	Kininogens (Kininogen)
6.	Aldosterone
7.	Potassium
8.	Creatinine
9.	Captopril (Capoten)
10.	Complementary DNA (cDNA)

Related Therapies and Procedures

1.	Prostatectomy (Retropubic Prostatectomy)
2.	Nephrectomy
3.	Kidney Transplantation
4.	Sodium-Restricted Diet (Diet, Sodium Restricted)
5.	Investigational Therapies (Experimental Therapy)

Best Treatments:
Research Summary Report
on Hypertension

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 3762 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents